Skip to content

GP Endorsement of Bowel Screening

Evaluating the effectiveness of GP endorsement in increasing participation in the NHS Bowel Cancer Screening Programme: A feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86784060
Enrollment
4380
Registered
2011-09-29
Start date
2011-09-26
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Cancer Cancer Malignant neoplasm of other digestive organs

Interventions

The study population will be adults aged 60 to 74 who have been invited to participate in bowel screening but who have not returned their Faecal Occult Blood Test (FOBt) kit within the 13 week ?screen

Sponsors

University of Birmingham (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults aged 60 to 74 2. Non-responders to previous invitation to participate in NHS Bowel Cancer Screening Programme 3. Target Gender: Male & Female

Exclusion criteria

Exclusion criteria: 1. Recently undergone an investigation and/or are currently under surveillance. 2. Moved outside age range for screening. 3. Have contacted Hub requesting no further contact.

Design outcomes

Primary

MeasureTime frame
The difference in the uptake rate of FOBt screening for bowel cancer (i.e. completion and return of FOBt kit) between the intervention and control groups at 13 weeks after the GP endorsed reminder and duplicate FOBt kit are sent.

Secondary

MeasureTime frame
1. Subgroup analyses of uptake by gender, age and deprivation 2. The development and validation of methods for collecting data on intervention costs 3. Qualitative work (30-40 semi-structured interviews) will be undertaken with individuals in the intervention arm who return a FOBt kit. This will investigate the relative importance of the duplicate FOBt kit, reminder to participate, and GP endorsement of that reminder in contributing to individuals? decisions to participate in screening. If the feasibility work demonstrates a significant increase in uptake of FOBt screening in individuals receiving the intervention, a future definitive trial can be designed and appropriately powered.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026